Lorlatinib Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jun 15, 2026 · last update Jun 15, 2026
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03) | Pfizer Inc. | To Be Discontinued | — | Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentation | Posted Jun 15, 2026 Updated Jun 15, 2026 Discontinued Jun 15, 2026 |